<DOC>
	<DOCNO>NCT00723125</DOCNO>
	<brief_summary>In MDACC/BrUOG neoadjuvant trial weekly paclitaxel follow Fluorouracil Plus Doxorubicin Cyclophosphamide ( FAC ) , pathologic complete response ( pCR ) rate HER2 ( - ) patient 20 % . The investigator ' goal develop induction chemotherapy regimen pCR rate 30 % patient HER2 ( - ) disease . Based 1-sided 95 % confidence interval use normal approximation expect pCR rate least 35 % , approximately 28 patient require cohort . With assumed pCR rate least 35 % , investigator approximately 70 % statistical power conclude , 90 % certainty , pCR rate novel regimen exceed 20 % . The study accrue approximately 60 patient two cohort inevaluable rate exceed 10 % .</brief_summary>
	<brief_title>Carboplatin , Abraxane , Avastin Neoadjuvant Therapy Her2-Negative Breast Cancer</brief_title>
	<detailed_description>See brief summary</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Eligibility criterion Inclusion criterion : Histologically document adenocarcinoma breast ANC &gt; 1000 cell Female ; age &gt; 18 Zubrod PS 01 Platelets &gt; 100,000 Stage IIAIIIB disease Total bilirubin &lt; 1.5 ULN No evidence metastatic disease Serum Creatinine &lt; 1.5 gm/dl No prior systemic therapy breast cancer Creat Cl &gt; 30 ml/min Not pregnant lactate Serum ALT &lt; 2.0 ULN ER , PR HER2 status require LVEF ( MUGA/echo WNL ) No baseline &gt; 2 neuropathy Urine protein : creat ratio &lt; 1.0 HER2negative either IHC 01+ FISH ratio &lt; 2.0 Hemoglobin &gt; 9 gm/dl ( FISH testing require HER2 23+ tumor IHC ) Exclusion criterion : No Histologically document adenocarcinoma breast NoANC &gt; 1000 cell Female ; age &lt; 18 Zubrod PS &gt; 01 Platelets &lt; 100,000 Stage IV disease Total bilirubin &gt; 1.5 ULN metastatic disease Serum Creatinine &gt; 1.5 gm/dl prior systemic therapy breast cancer Creat Cl &gt; 30 ml/min pregnant lactate Serum ALT &gt; 2.0 ULN baseline &gt; 2 neuropathy Urine protein : creat ratio &gt; 1.0 HER2positive Hemoglobin &lt; 9 gm/dl</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Breast Cancer</keyword>
</DOC>